Validation of a Novel Magnetic Resonance Imaging Biomarker of Infarct Severity to Predict Functional Outcome After Endovascular Thrombectomy.

Favilla, Christopher G; Regenhardt, Robert W; Denny, Braden; Shakibajahromi, Banafsheh; Patel, Aman B; Mullen, Michael T; Leslie-Mazwi, Thabele M; Dmytriw, Adam A et al. · Stroke · 2025

retrospective_cohort · Level III

Where this comes from

Abstract

Endovascular thrombectomy (EVT) dramatically improves clinical outcomes, but the final infarct volume (FIV) on magnetic resonance imaging only accounts for a minority of the treatment effect. An imaging biomarker that more strongly correlates with post-EVT functional outcome would be helpful for clinical prognosis and serve as a surrogate outcome measure in trials of EVT-adjuvant therapies. Here, we aimed to validate a novel magnetic resonance imaging-based metric, infarct density, which leverages post-EVT apparent diffusion coefficient as a marker of infarct severity. A retrospective cohort was derived from a single-center prospective EVT registry. Consecutive patients treated with EVT for anterior circulation large vessel occlusion were included from 2018 to 2019 who achieved successful reperfusion (modified Thrombolysis in Cerebral Infarction ≥2b). Magnetic resonance imaging was performed 12 to 48 hours post-EVT and processed via RAPID to quantify FIV using the apparent diffusion coefficient <620 threshold. Lesion volume was also collected using an apparent diffusion coefficient <470 threshold, and infarct density was calculated as: (volume <470/volume <620)×100%. Good outcome was defined as ≤2 on the 90-day modified Rankin Scale. Multivariable logistic regression models quantified the association between clinical/imaging variables and outcome. Receiver operating characteristic analysis quantified model classification performance. Of 319 patients treated with EVT, 272 met inclusion criteria. The mean age was 69±13 years, 41% were female, and 62% achieved a good outcome. After adjusting for clinical and radiographic factors, FIV (adjusted odds ratio, 0.99 per 1 mL [95% CI, 0.98-1.00]; <i>P</i>=0.03) and infarct density (adjusted odds ratio, 0.95 per 1% [95% CI, 0.94-0.97]; <i>P</i><0.001) were both independently inversely associated with good outcome. The final model incorporating both FIV and infarct density achieved excellent classification performance (area under the curve, 0.87 [95% CI, 0.83-0.91]). Removing infarct density from the model diminished its performance (area under the curve, 0.83 [95% CI, 0.78-0.88]; <i>P</i>=0.01). Apparent diffusion coefficient-based infarct density after EVT is independently associated with long-term outcome and provides greater prognostic information than FIV alone. Post-EVT infarct density may be useful in clinical care and as a surrogate outcome measure in trials of EVT-adjuvant therapies.

Medical subject headings